髂静脉支架植入在导管导向溶栓治疗深静脉血栓后的中期效果
回顾性分析2009年1月至2014年12月73例急性下肢深静脉血栓形成(DVT)伴髂静脉压迫、行导管导向溶栓(CDT)后的患者,分为支架组(n=40)与非支架组(n=33)。随访88条肢体平均38.38±14.91个月,支架组深静脉通畅率85.17±25.62 vs 非支架组54.61±40.42(P<0.05),Villalta评分1.73±2.86 vs 4.39±5.16(P<0.05),CEAP临床分级差异有统计学意义。结论认为支架植入增加深静脉通畅率并改善中期生活质量。
要点
- CDT后对严重狭窄髂静脉段植入支架,深静脉通畅率85.17±25.62 vs 非支架组54.61±40.42(P<0.05)。
- 支架组Villalta评分1.73±2.86 vs 非支架组4.39±5.16(P<0.05),中期生活质量更优。
- CEAP临床分级两组差异有统计学意义(P<0.05)。
核心结论
- CDT后对严重狭窄髂静脉段植入支架,较非支架组增加深静脉通畅率并改善中期生活质量。
研究设计与样本
- 回顾性分析2009年1月至2014年12月73例急性下肢DVT伴髂静脉压迫、CDT后患者,男32例女41例,平均年龄53.57±15.60岁(中位45岁,范围20-79岁)。
- 按是否植入支架分为支架组(n=40)与非支架组(n=33),随访88条肢体(单侧58例、双侧15例),平均38.38±14.91个月。
主要发现
- 深静脉通畅率支架组85.17±25.62 vs 非支架组54.61±40.42,差异有统计学意义(P<0.05)。
- CEAP分类中C(临床表现)两组差异有统计学意义(P<0.05)。
- Villalta评分支架组1.73±2.86 vs 非支架组4.39±5.16,差异有统计学意义(P<0.05)。
临床怎么用
- 原文结论认为CDT后对严重狭窄髂静脉段植入支架可增加深静脉通畅率并改善中期生活质量。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: When following catheter-directed thrombolysis (CDT) for deep vein thrombosis (DVT), the stenosed iliac veins is controversy. To evaluate the mid-term outcomes of CDT with or without stent implantation for DVT in the presence of iliac vein compression. METHODS: Seventy-three patients with iliac vein compression following CDT for acute lower extremity DVT from January 2009 to December 2014 were retrospectively analyzed. There were 32 males and 41 females, with average age of 53.57 ± 15.60 years (median: 45 years, range: 20-79 years). After CDT, patients with iliac vein compression were divided into 2 groups: the stenting group (n = 40) and the nonstenting group (n = 33). Patency rate of the deep vein, chronic change of vessels, clinical, etiological, anatomical, and pathological elements (CEAP) classification, venous clinical severity score, and Villalta scale were chosen to evaluate the midterm and long-term outcomes. RESULTS: Eighty-eight limbs among the patients (58 unilateral and 15 bilateral) were followed with mean time of 38.38 ± 14.91 months. The difference in vein patency between 2 groups (85.17 ± 25.62 vs. 54.61 ± 40.42) was statistically significant (P < 0.05). According to the C in CEAP classification, the difference in clinical manifestations between the 2 groups was statistically significant (P < 0.05). In addition, the Villalta scale scores were also significantly different between the 2 groups (1.73 ± 2.86 vs. 4.39 ± 5.16, P < 0.05). CONCLUSIONS: Stent implantation in severely stenosed iliac segments following CDT for lower extremity DVT increased the patency of deep veins and improved midterm quality of life compared with that of nonstenting.
引用
- Yu H, Du X, Li W, et al. The Midterm Effect of Iliac Vein Stenting following Catheter-directed Thrombolysis for the Treatment of Deep Vein Thrombosis. Ann Vasc Surg. 2018. PMID: 29496568. doi:10.1016/j.avsg.2018.01.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。